Aldosterone Antagonism Improves Endothelial-Dependent Vasorelaxation in Heart Failure via Upregulation of Endothelial Nitric Oxide Synthase Production-Reference-Cited by-同舟云学术

Aldosterone Antagonism Improves Endothelial-Dependent Vasorelaxation in Heart Failure via Upregulation of Endothelial Nitric Oxide Synthase Production

Published:2006-04 Issue:3 Volume:12 Page:240-245
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Thai Hoang M.,Do Bao Q.,Tran Trung D.,Gaballa Mohamed A.,Goldman Steven

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference46 articles.

1. Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure;Swedberg;Am J Cardiol,1990

2. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality;Swedberg;Circulation,1990

3. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure;The SOLVD Investigators;N Engl J Med,1988

4. the Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin receptor valsartan in chronic heart failure;Cohn;N Engl J Med,2001

5. The effect of spironolactone on morbidity and mortality in patients with severe heart failure;Pitt;N Engl J Med,1999

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of esaxerenone on circulating microparticles and vascular endothelial function in diabetic mice;2024-05-08

2. A Selective Mineralocorticoid Receptor Blocker, Esaxerenone, Attenuates Vascular Dysfunction in Diabetic C57BL/6 Mice;Journal of Atherosclerosis and Thrombosis;2023-04-01

3. Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy;ESC Heart Failure;2021-01-05

4. Monophasic action potential amplitude for substrate mapping;American Journal of Physiology-Heart and Circulatory Physiology;2019-10-01

5. Spironolactone ameliorates endothelial dysfunction through inhibition of the AGE/RAGE axis in a chronic renal failure rat model;BMC Nephrology;2019-09-06